# CCI clears Advent International’s Rs 3,150-crore Yatharth Hospitals deal

2026-11-10T15:12:31+00:00 | Business & Economy | Indian Opinion Desk

Corroboration: 3 independent outlets (4 source reports)

The Competition Commission of India (CCI) on Tuesday, 10 November 2026, approved US private equity firm Advent International's proposal to invest Rs 3,150 crore in Yatharth Hospital & Trauma Care Services through its affiliate Rasmalai Ltd. The investment, announced in September, will give Advent a 24.9 per cent minority stake in the Noida-based hospital chain. Yatharth Hospitals plans to use the primary capital infusion to expand its network and increase its bed capacity from 2,800 beds to more than 5,000 beds over the next three years, as per its FY26 annual report. The founding Tyagi family will remain the largest shareholder after the deal. The CCI, which examines mergers above certain thresholds under the Competition Act, 2002, has yet to publish a detailed order. The hospital chain reported a 17.45 per cent rise in consolidated net profit to Rs 48.45 crore for the September quarter, with revenue from operations at Rs 431.42 crore. Advent's affiliate Rasmalai Ltd, incorporated in Cyprus, currently has no business presence in India.

## Indian Opinion Analysis

All three outlets carried near-identical wire copy of the CCI clearance, with uniform factual coverage of the Rs 3,150-crore figure, the 24.9 per cent stake and the September announcement. Business Standard added the expansion target of 5,000 beds over three years from the company's FY26 annual report, a detail the other two omitted. The Hindu Business Line and the Economic Times led with the CCI approval and the profit numbers, while Business Standard fronted the investment size and the primary capital structure. The coverage is straight reporting across the board, with no discernible slant: every outlet stuck to the regulator's statement and the company's September disclosure. The key open point is the CCI's detailed order, which all sources note is awaited.

## Coverage

Coverage: 2 sources, 2 neutral
- Syndicated copy <https://www.thehindubusinessline.com/companies/cci-clears-advent-internationals-3150-crore-investment-in-yatharth-hospitals/article71686456.ece>
- thehindubusinessline.com <https://www.thehindubusinessline.com/companies/cci-clears-advent-internationals-3150-crore-investment-in-yatharth-hospitals/article71686456.ece>
  Wire-copy style, no slant, includes profit figures
- economictimes.indiatimes.com <https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/cci-clears-advent-internationals-rs-3150-crore-investment-in-yatharth-hospital/articleshow/135713222.cms>
  Identical wire copy, no added commentary
- business-standard.com (neutral report) <https://www.business-standard.com/companies/news/cci-approves-advent-s-3-150-crore-investment-in-yatharth-hospitals-126111000820_1.html>
  Straight reporting, adds capacity target from annual report

This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry.

Tags: Advent International, CCI, Competition Act, Rasmalai Ltd, Yatharth Hospitals
Canonical: https://indianopinion.org/cci-clears-advent-internationals-rs-3150-crore-yatharth-hospitals-deal/
License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources.
Cite: https://indianopinion.org/cci-clears-advent-internationals-rs-3150-crore-yatharth-hospitals-deal/#story-in-brief

How this brief was made: an AI model read the reports linked above and wrote this summary and analysis, which were published automatically. Published briefs are sampled every hour by an automated quality check; the editor verifies its findings and approves corrections, and corrected briefs carry a dated correction line. Stance labels are editorial classifications of how each outlet framed this story, assigned by the same model, not ratings of the outlets. We do no original reporting. Methodology: https://indianopinion.org/ai-use-policy/
